格隆汇1月13日丨先声药业(02096.HK)公告,于2025年1月13日,集团附属公司山东先声生物制药有限公司("山东先声")与AbbVieInc.(股票代码:ABBV)附属公司订立许可选择权协议。根据该协议条款,AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤(MM)患者进行临床I期研究。根据该协议条款,集团将从Abb ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.